£890.00

It has never been this cheap. We have no record of a lower price.

£890 today · cheaper than every other day in the last 2 months

2027-2032 World Outlook for Transitional Cell Bladder Cancer Therapeutics

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 4 days · 4 data points (no recent data)

Historical
Generating forecast…
£890.00 £845.50 £863.30 £881.10 £898.90 £916.70 £934.50 25 September 2026 25 September 2026 26 September 2026 27 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 4 days • 1 price levels

Days at Price
4 days 0 1 2 3 4 £890 Days at Price

Price Analysis

Most common price: £890 (4 days, 100.0%)

Price range: £890 - £890

Price levels: 1 different prices over 4 days

Description

This comprehensive market analysis study examines the global outlook for transitional cell bladder cancer therapeutics across more than 190 countries over the 2027-2032 period. The report provides detailed estimates of latent demand and potential industry earnings (P.I.E.) for each country in millions of U.S. dollars, along with each nation's percentage share of its region and the global market. These comparative benchmarks enable readers to assess individual countries against their peers and identify emerging opportunities within the therapeutic landscape. Utilising econometric models that project fundamental economic dynamics at both national and international levels, the study delivers robust latent demand forecasts grounded in rigorous quantitative analysis. Ideal for pharmaceutical companies, healthcare investors, market researchers, and policy makers seeking data-driven insights into bladder cancer therapeutic markets worldwide.

Key Features

Covers transitional cell bladder cancer therapeutics market data for more than 190 countries across the 2027-2032 forecast period.

Provides latent demand and potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for each country analysed.

Includes comparative benchmarks showing each country's percent share of regional and global therapeutic markets.

Utilises econometric models to project fundamental economic dynamics and generate reliable demand forecasts.

Published by ICON Group International, Inc., a recognised provider of global market intelligence and industry analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
05 January 2026
Listed Since
03 March 2026

Similar Products You Might Like

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
91% match

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines

£795.00 13 Sep 2026
The 2025-2030 World Outlook for Immuno-Oncology
91% match

The 2025-2030 World Outlook for Immuno-Oncology

£790.00 28 Sep 2026
The 2023-2028 World Outlook for Overactive Bladder Treatments
90% match

The 2023-2028 World Outlook for Overactive Bladder Treatments

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Endometrial Cancer Treatments
89% match

The 2023-2028 World Outlook for Endometrial Cancer Treatments

£795.00 15 Sep 2026
The 2027-2032 World Outlook for Peripheral Neuropathy Treatments
88% match

The 2027-2032 World Outlook for Peripheral Neuropathy Treatments

£890.00 22 Sep 2026
The 2027-2032 World Outlook for Bronchodilators
88% match

The 2027-2032 World Outlook for Bronchodilators

£890.00 22 Sep 2026
2026-2031 World Outlook for Biotherapeutics Cell Line Developments
88% match

2026-2031 World Outlook for Biotherapeutics Cell Line Developments

£885.00 28 Sep 2026
2026-2031 World Outlook for Natural Killer Cell Therapeutics
88% match

2026-2031 World Outlook for Natural Killer Cell Therapeutics

£885.00 28 Sep 2026
The 2027-2032 World Outlook for Pain Management Therapeutics
88% match

The 2027-2032 World Outlook for Pain Management Therapeutics

£890.00 22 Sep 2026
The 2027-2032 World Outlook for Inhalation and Nasal Spray Drugs
88% match

The 2027-2032 World Outlook for Inhalation and Nasal Spray Drugs

£890.00 22 Sep 2026
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
88% match

The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs

£795.00 15 Sep 2026
The 2023 Report on Hormone-Drug Breast Cancer Therapeutics: World Market Segmentation by City
88% match

The 2023 Report on Hormone-Drug Breast Cancer Therapeutics: World Market Segmentation by City

£795.00 15 Sep 2026
The 2026-2031 World Outlook for Drug Repurposing
87% match

The 2026-2031 World Outlook for Drug Repurposing

£885.00 28 Sep 2026
The 2026-2031 World Outlook for Drug Delivery across Blood Brain Barriers
87% match

The 2026-2031 World Outlook for Drug Delivery across Blood Brain Barriers

£885.00 28 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
87% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments
87% match

The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments

£795.00 15 Sep 2026
2027-2032 World Outlook for Angiogenesis Inhibitors and Stimulators
87% match

2027-2032 World Outlook for Angiogenesis Inhibitors and Stimulators

£890.00 28 Sep 2026
2027-2032 World Outlook for Community Acquired Pneumonia
87% match

2027-2032 World Outlook for Community Acquired Pneumonia

£890.00 28 Sep 2026
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
87% match

The 2025-2030 World Outlook for Non-Melanoma Skin Cancers

£790.00 28 Sep 2026
The 2027-2032 World Outlook for Virology
87% match

The 2027-2032 World Outlook for Virology

£890.00 12 Nov 2026
The 2027-2032 World Outlook for Animal Pharmaceuticals
86% match

The 2027-2032 World Outlook for Animal Pharmaceuticals

£890.00 17 Sep 2026
The 2026-2031 World Outlook for Anti-Smoking Drugs
86% match

The 2026-2031 World Outlook for Anti-Smoking Drugs

£885.00 22 Sep 2026
The 2023-2028 World Outlook for Type 1 Spinal Muscular Atrophy
86% match

The 2023-2028 World Outlook for Type 1 Spinal Muscular Atrophy

£795.00 15 Sep 2026
The 2026-2031 World Outlook for Healthcare Contract Research Organizations
86% match

The 2026-2031 World Outlook for Healthcare Contract Research Organizations

£885.00 28 Sep 2026